CXCR2 and cancer: Next, we investigated the effect of treatment by the small molecule inhibitors EC330 (a small molecule compound that effectively inhibits the function of LIF in promoting the proliferation and migration of cancer cells 31) and SB225002 (targeting CXCR2) on lung metastasis.